Assessment of the Safety, Efficacy, and Benefit of Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Heart Failure With Reduced Ejection Fraction (HFrEF) at High Risk for Cardiovascular Events
| Autor: | Ruba Towiargi, Lama Fetyani, Naila Aljahdali, Adnan Alnofeie, Yahya Alnoamy, Reham Ghandorah, Abrar Abduljawad, Njood Alharbi, Alanoud Alghanmi, Hala AlButi |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Cureus. |
| ISSN: | 2168-8184 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|